Regulations in U.S and Europe make it prohibitive to create drugs for people that will not be used by a LOT of people. Most of these countries now offer benefits to drugs that will benefit groups of people, generally speaking, 100k or fewer. These benefits revolve around tax preference and sometimes grants. This is orphan status. Cheers.